Recombinant peptide vaccines against ticks, and nucleotide sequences coding for the recombinant peptides

Abstract

The present invention relates to the field of biotechnology and genetic engineering, and particularly to the expression of recombinant peptides. The inoculation thereof in cattle results in the production of an immune response capable of adversely affecting Rhipicephalus microplus ticks, which feed on the inoculated cattle, decreasing the number and reproductive capacity of this tick species. Such recombinant immunogen can be used as an effective vaccine for tick control. The technical goal is the design and construction of two synthetic genes made with preferred codons for Pichia pastoris and expression thereof from a recombinant peptide, which consists in a continuous sequence and of a recombinant peptide, respectively, and the drug composition based of said recombinant polypeptide.

Claims

1. A nucleotide sequence selected from the group comprising SEQ ID NO: 2, wherein said nucleotide sequences encode one or more peptides for expression in Pichia pastoris.

Description

DESCRIPTION OF THE DRAWINGS

(1) FIG. 1Kinetics of antibodies in animals immunized with SEQ ID NO. 3. The arrows indicate inoculation and the star the time of challenge with larvae of Rhipicephalus (B.) microplus. The T bars indicate the difference by the adding of a standard deviation.

(2) FIG. 2Kinetics of antibodies in animals immunized with SEQ ID NO. 4. The arrows indicate inoculation and the star the time of challenge with larvae of Rhipicephalus (B.) microplus. The T bars indicate the difference by the adding of a standard deviation.

DETAILED DESCRIPTION OF THE INVENTION

(3) Obtaining Encoding Sequences

(4) Two genes called seq1 (SEQ ID NO: 1) and seq4 (SEQ ID NO: 2) were designed from the reverse vaccinology methodology using as base the synthetic peptide on the SBm7462 for use in P. pastoris yeast km71. The seq4 gene was constructed in order to express a similar copy of SBm7462. However, the seq1 gene was designed to express the peptide repeated three times in tandem. The genes were designed with preferred codons for P. pastoris. For the genes drawings, the cloning sites of the expression vector used were taken into consideration. The vector used has an insertion region of heterologous fragments composed of several restriction sites for enzymes called (XhoI, SnaBI, EcoRI, AvrII and NotI).

(5) Construction of Expression Cassettes seq1 (SEQ ID NO: 1) and seq4 (SEQ ID NO: 2)

(6) The sequences corresponding to the genes were cloned into the pPIC9 vector, which was subjected to cleavage with appropriate restriction enzymes. Through these divisions, sticky ends were formed on both vectors and genes, allowing the connection of the genes in the correct ORFs (Open Reading Frame) in their respective expression vectors. All cleavage reactions were analyzed by agarose gel electrophoresis 0.8%. The construction of the cassettes were given through the use of the enzyme T.sub.4DNA ligase, whose function was to catalyze the bonding of the cohesive ends of the strands 5-3 of the vector with the 3-5 of the gene and vice versa.

(7) Analyses of the Expression Cassettes by Colony PCR and Sequencing.

(8) The constructed expression cassettes were multiplied in E. coli DH5a. Clones of each gene were analyzed by colony PCR and subsequently sequenced in order to verify the correct presence of the gene in the expression cassette.

(9) The clones confirmed by sequencing were subjected to growth in LB liquid medium at 37 C., under 250 rpm orbital shaking for 16 hours for subsequent extraction of the expression cassettes that were used to transform the yeast Pichia pastoris KM71.

(10) Preparations of Cassettes seq1 (SEQ ID NO: 1) and seq4 (SEQ ID NO: 2) for Electroporation.

(11) For the transformation of P. pastoris km71 by electroporation, the expression cassettes were linearized with restriction enzyme Scl (WU and LETCHWORTH, Drug Discovery and Genomic Technologies, 36:152-154, 2004).

(12) In each cleavage reaction, it was used approximately 20 g of plasmid DNA in excess of three times the enzyme at 37 C. and overnight.

(13) The monitoring of the cleavage was carried out before the end of the reaction by gel electrophoresis in 1% agarose, stained with ethidium bromide, and visualization under UV light. After verification of the total linearization of the expression cassettes, the entire reaction was applied in adjacent channels on 0.8% agarose gel and subjected to electrophoresis. The extraction of the bands containing the linearized plasmid was given using appropriate commercial kit. The extracted material was subsequently precipitated with ethanol in order to concentrate it to 10 g in 10 uL of nuclease-free water, which was the final volume used in the transformation of the yeast.

(14) P. pastoris Km71 Yeast Transformations with the Expression Cassettes and Selection in MD Medium.

(15) The genetic transformation of the yeast P. pastoris km71 occurred by electroporation technique. To this, 10 g of each plasmid previously linearized with the restriction enzyme were added to 80 L of electronically competent cells and transferred to 0.2 cm electroporation cuvettes. The DNA and P. pastoris km71 mixture was kept on ice for 5 minutes to allow thermal equilibration of the solution. After this period, the cuvettes were placed in electroporation cell and subjected to an electrical pulse (1.5 kV, 25 g, and 200).

(16) Immediately after electroporation, 1 mL of sorbitol 1M was added in the electroporation chamber and kept in the ice bath for 5 minutes. After this period, 200 L of the transformants were plated on MD solid medium lacking histidine (YNB 1.34%, biotin 410.sup.5%, dextrose 2% and bacteriological agar 1.5%). For all transformed clones, plating were made in duplicates. The plates were maintained at 30 C. for 72 hours until complete growth of the clones. The selection with the MD medium is due because only the yeasts transformed with the vector pPIC9 develop due to the presence of the histidinol dehydrogenase gene that synthesizes the amino acid histidine.

(17) Confirmations of P. pastoris Km71 Clones by Polymerase Chain Reaction (PCR).

(18) Besides the selection of transformed clones of P. pastoris Km71 by the passage in medium lacking histidine (MD), clones of each gene were subjected to the extraction of total DNA and amplification thereof by PCR.

(19) The chromosomal DNA of the previously selected clones was extracted from cultures grown in liquid MD under 250 rpm stirring for 48 hours at 30 C. The culture was recovered by centrifugation, for 10 minutes, at 5000 g at room temperature. The pellet was resuspended in 400 L of extraction solution (Triton 100 2%, SDS 1%, NaCl 100 mM, Tris-HCl 100 mM and EDTA 10 mM, pH 8.0), and transferred to a 2 mL tube containing 300 mg of glass beads of 0.45 mm in diameter used for mechanical lysis of the yeast through orbital shaking vigorously for 2 minutes. Subsequently, 200 L of phenol and 200 L of chloroform were added and again proceeded to vigorous shaking for two minutes to enhance lysis of cells and subsequent DNA extraction. After this phase, the solution was centrifuged for 5 minutes at 5000 g. The aqueous phase was transferred to a new tube and treated with RNAse (10 L of a 10 mg/mL solution) for 1 hour at 37 C. and, right after, with proteinase K (20 L of a 10 mg/mL solution) for 2 hours at 37 C. The precipitation was performed by adding 1/10 volume of sodium acetate pH 5.2, plus 2 volumes of cold absolute ethyl alcohol. The solution was gently stirred and kept at 20 C. for two hours to increase the yield of DNA precipitation and then centrifuged for 5 minutes at 5000 g. The pellet was washed with 70% ethanol for two successive centrifugations and dried at room temperature. Subsequently, the DNA was re-suspended in 100 L of nuclease-free water, quantified in agarose gel 1% with lambda DNA, and stored at 20 C. until use.

(20) To determine the insertions of the genes in yeast chromosome it was used the PCR technique and the primers 5AOX1 (5-GACTGGTTCCAATTGACAAGC-3) [SEQ ID NO: 5] and 3AOX1 (5-GCAAATGGCATTCTGACATCC-3) [SEQ ID NO: 6].

(21) Selections of seq1 (SEQ ID NO: 1) and seq4 (SEQ ID NO: 2) Clones by Colony Blotting.

(22) The P. pastoris Km71 clones preselected through MD and PCR for recombinant expression were selected by protein production analysis by Western Blotting colony. The technique was chosen because the yeasts transformed with the cassette SEQ ID NO: 1 and SEQ ID NO: 2 export the expressed protein into the extracellular medium. For that, clones transformed with SEQ ID NO: 1 and SEQ ID NO: 2 were selected randomly. These two clones were plated on petri dishes containing the solid YPD medium until the colonies reach a mean diameter of 3 mm, in an oven at 30 C. Once reaching the required size with the aid of a nitrocellulose membrane, the clones were collected and transferred by imprint and passed to other two of MM expression medium containing plates (YNB 1.34%, biotin 410.sup.5%, methanol 0.5% and bacteriological agar 1.5%) with a 0.2 m nitrocellulose membrane equilibrated in this medium at 30 C. for 12 hours. The imprints were placed in direct contact with the 0.2 m membranes, taking care to remove all air between the membranes. The plates were incubated at 30 C. for 72 hours, necessary time to have an optimum proteins expression and their transfer to the membrane.

(23) After the genes induction period, the nitrocellulose membranes were collected so to avoid the drag of the colonies as much as possible. Subsequently, the nitrocellulose membranes were treated with methanol 100% for 1 minute to fix the protein and immediately subjected to 3 successive washings, 20 seconds each, with Milli-Q water.

(24) The detection of producing clones was performed by enzyme immunoassay dot-blotting. Thereunto, the membranes were blocked with PBST 0.05% pH 7.6 (NaCl 4.25 g; Na.sub.2HPO.sub.4 0.64 g; NaH.sub.2PO.sub.4.H.sub.2O 0.068 g; Tween-20 0.05% and H.sub.2O Milli-Q q.s.p. 500 mL) for 30 minutes under side agitation. After this step, the membranes were subjected to three successive washes with PBST 0.05% for 5 minutes each and, then, incubated for two hours with anti-synthetic peptide rabbit serum SBm7462 diluted at 1:100 (positive control) and the other with normal rabbit serum, or not immunized with the synthetic peptide SBm7462, diluted at 1:100 (negative control). Immediately after the incubation, the membranes were again subjected to three washes of 5 minutes each with PBST 0.05% and then incubated with peroxidase labeled protein A diluted at 1:400 for 1 hour.

(25) The development of the reaction took place after two washes of 5 minutes each with PBST 0.05% and once with PBS pH 7.6. The substrate was formulated with 10 mg of DAB (diaminobenzidine), 10 mL of Tris-HCl 0.05M pH 7.6; 1 mL of NiCl.sub.2 0.3% and 10 L of H.sub.2O.sub.2 30%. The solution was stirred together with the membranes until the early appearance of the background on the negative control. At this time, the reaction was stopped by washing the membrane with Milli-Q water.

(26) Stability Evaluation of the Recombinant Clones

(27) To evaluate the genetic stability of the recombinants, they were transferred to YPD agar (yeast extract 10 g/L, peptone 20 g/L, glucose 20 g/L, bacteriological agar 20 g/L) and incubated at 30 C. until the appearance of isolated colonies. Thereafter, five colonies of each transformant were successively transferred to non-selective complete medium, YPD, with a total of ten passes. Each pass through the plates were incubated at 30 C. for 72 hours. At the end of the fifth passage, the colonies were transferred to selective MD medium lacking histidine and incubated at 30 C. for a further 72 hours.

(28) Production of Peptides in Bench Fermenter

(29) Pre-Inoculum:

(30) A P. pastoris clone, frozen with glycerol, at a culture-glycerol ratio of 70%/30%, kept in ultrafreezer (70 C.), is thawed on ice and grown in 500 mL erlernmeyer containing 250 mL of Medium B (Table 1) at 30 C., and orbital agitation of 250 rpm for 2 days. The sterility of the biomass was examined by light microscopy.

(31) TABLE-US-00001 TABLE 1 Composition of Part B. Amount used for 1 L KH.sub.2PO.sub.4 13 g (NH.sub.4).sub.2SO.sub.4 8.75 g MgSO.sub.4 4.5 g CaCl.sub.22H.sub.2O 0.5 g Yeast extract 2.5 g Glycerol 40 mL pH 5.0. Must be autoclaved.
Fermentation:

(32) The production of recombinant antigen on a laboratory scale is carried out by fermentative processes in a bioreactor. To the pre-inoculum, 21 mL of PTM1 Trace Salts (Table 2) and 1 mL of antifoam are added. This mixture is placed in a sterile flask with cannula adapted to the bioreactor and added to the 4.5 L of sterile medium B already in the reactor through positive pressure. The reactor is then turned on and the parameters are maintained constant: 2 mmHg oxygen continuous injection, 600 rpm rotation and water jacket maintained at 30 C. The pH is maintained between 5 and 5.5, adjusted with ammonium hydroxide 50% or phosphoric acid 50% diluted in autoclaved water. The buffer are kept in separate flasks connected to the peristaltic pump, which is programmed for automatic pH correction.

(33) TABLE-US-00002 TABLE 2 Composition of PTM1* Medium. Amount used for 1 L CuSO.sub.45H.sub.2O 6 g NaI 0.08 g MnSO.sub.4H.sub.2O 3 g Na.sub.2MoO.sub.42H.sub.2O 0.2 g Boric Acid 0.02 g CoCl.sub.2 0.5 g ZnCl.sub.2 20 g FeSO.sub.47H.sub.2O 65 g Biotin 0.2 g Sulfuric acid 5 mL *must be filtered
Feeding

(34) As the oxygen parameters dissolved in the medium are monitored, and taking into account that the oxygen levels remained low for the consumption, during the biomass growth and multiplication phase, when it rises reaching around 90%, which is approximately 2 days after the start of the fermentation, 400 mL of a sterile solution is added to the medium containing glycerol 50% in water and 6 mL of PTM1/L. After that, dissolved oxygen values should fall again, indicating return to their consumption and multiplication.

(35) Induction

(36) When all source of carbon provided (glycerol) have been exhausted, the dissolved oxygen parameter will further increase which occurs approximately 3 days after feeding. At this point, begins the induction of the recombinant peptide production with pure methanol, in that a final volume of 400 mL of methanol is added to the culture for 4 days at 1-hour intervals. In the first two hours, a volume of approximately 2 mL is added to the culture adaptation to the new carbon source and, from the 3rd hour, about 4 mL/h, and remains so until the end of the total volume. It is also added separately 1 ml of PTM1 daily.

(37) Purification

(38) [01] After the induction period, the culture is centrifuged at 4 C. for 15 minutes at 4500 rpm. The supernatant is then subjected to cross-flow filtration, first being clarified in 100 kDa filter, form which the permeable, i.e., the content weight lower than 100 kDa, is collected and subjected to new filtration in 30 kDa filter, where again all permeable is collected. The filtration product is subjected, by the same tangential filtration system, to a dialysis with milli-Q water chilled to 4 C. The sterilization of the product is done by filtration through 0.45 m membrane and collected in sterile flasks. The sterilization tests are done by inoculating in Sabureau medium and blood agar maintained in bacteriological greenhouse at 37 C. for 96 hours.

(39) Subsequently, the protein is measured to quantify the dose and packaged in polyurethane flasks, and stored under refrigeration at 4 C.

(40) The recombinant peptides identified as SEQ ID NO: 3 and SEQ ID NO: 4, encoded by SEQ ID NO: 1 and SEQ ID NO: 2, respectively, were used as immunogens to the Rhipicephalus (B.) microplus tick control.

(41) Demonstration Experiment

(42) Efficiency Evaluation of Recombinant Immunogens SEQ ID NO: 3 and SEQ ID NO: 4

(43) 20 crossbred male cattle were used (H/Z), blood average 7/8, between 6 and 10 months old, coming from dairy farms in the County of Vicosa, MG estate, and maintained since its birth in the arthropod vectors proof cattle isolation.

(44) The animals were identified by numbered earrings. The feeding was based on balanced feed and forage (hay) with 17% protein, offered at 8 am and 4 pm and water ad libitum.

(45) The animals were randomly distributed into four groups of 04 animals each. The inoculations were performed in three doses, subcutaneously, as follows: First inoculation: day 0 (zero); Second inoculation: day 30; Third inoculation: day 60.

(46) The inoculation scheme is described below: Group SEQ ID NO: 3: saponin 1.5 mg added to recombinant peptide 1 mg diluted in 4 mL of sterile Milli-Q water. Group SEQ ID NO: 4: saponin 1.5 mg added to recombinant peptide 2 mg diluted in 4 mL of sterile Milli-Q water. Saponin adjuvant control group: saponin 1.5 mg diluted in 4 mL of sterile Milli-Q water. Control Group: 4 mL of sterile Milli-Q water. Pichia pastoris Group: crude extract of P. pastoris not transfected 2 mg diluted in 4 mL of sterile milli-Q water.

(47) The inoculated animals were constantly monitored, twice a day, for seven days after inoculation for verification of possible hypersensitivity skin reactions to recombinant peptides and adjuvant; besides the daily visual inspection, hematocrit tests were performed on all animals on the seven days after inoculation to observe some hemolytic effect of the recombinant peptides.

(48) Challenge and Infestation of the Cattle

(49) After 21 days of the last inoculation of the recombinant peptides, all animals were challenged with larvae of R. (B.) microplus, in the amount of 1,500 larvae per day for three days, beginning in the morning. Day 1breast and dewlap regions Day 2scapular and between the forelimbs regions Day 3scrotal and inguinal regions

(50) The animals were kept in halter and tied by the tail for 8 hours in order to correct fixation of the larvae. Biological Parameters Evaluation of the detached teleoginae After the challenge with tick larvae, daily observations were performed until the eighteenth day to check the development of the larvae, nymphs, and predict the likely beginning day of the detachment of teleoginae from the animals. At 21 days, with the beginning of the females fall, it was initiated the collecting procedure, manually, for all teleoginae found on the floor of the stalls, in the feeding trough, and in the grid for debris flow. For a more accurate collection, the bay was washed two times a day and, throughout this wash, the resulting material was sieved, and the removed teleoginae ticks were counted and identified.
Number of Teleoginae

(51) It was recorded the naturally detached teleoginae as well as the trampled.

(52) Weight of Teleoginae

(53) The female collected were washed in running water and weighed in analytical balance with a precision of 3 decimal places in order to determine the percentage of reduction of their average weight.

(54) Posture Weight

(55) After weighing, the females collected were individually wrapped and identified, and left in oviposition for two weeks in an oven at 27 C. and 80% relative humidity (OBA Revista da Faculdade de Veterinria e Zootecnia da Universidade de So Paulo 13: 409-420 1976). After the end of posture, the total posture weight of each group was evaluated.

(56) Larva Weight/Eggs Gram Ratio

(57) From the total eggs, twenty aliquots of 0.5 g (10,000 eggs) per group were separated in centrifuge tubes, making a total of 10 grams of eggs per group. The tubes were stoppered with cotton wool and the eggs incubated for 26 days in a 28 C. greenhouse and 80% relative humidity. Aliquots were taken at more than one day of eggs weighing. To obtain the results, the techniques described above were employed by (MASSARD et al., Revista Brasileira de Medicina Veterinria 17:167-173, 1995).

(58) Formulas for the Biological Parameters Evaluation

(59) In order to evaluate the effect of immunogens on the biological parameters of the tick, were employed the formulas advocated by DE LA FUENTE (Recombinant Vaccines for the control of cattle tick Habana: ELPOS Scientae, p. 280, 1995) used for vaccine groups and the control groups, as follows:
DT (%)=100[1(NTV/NTC)]
wherein:

(60) DT (%)Reduction percentage in the number of teleoginae

(61) NTVnumber of teleoginae for each vaccination group

(62) NTCnumber of teleoginae for control group.
DR (%)=100[1(PMTV/PMTC)]
wherein:

(63) DR (%)Reduction percentage in the average weight of teleoginae

(64) PMTVAverage weight of teleoginae for each vaccine group;

(65) PMTCAverage weight of teleoginae for control group.
DO (%)=100[1(PMOV/PMOC)]
wherein:

(66) DO (%)Reduction percentage of average weight of the eggs.

(67) PMOVAverage weight of the eggs for each vaccine group.

(68) PMOCAverage weight of the eggs for control group.
DF (%)=100[1(PPLOV/PPLOC)]
wherein:

(69) DF (%)Reduction in the eggs fertility.

(70) PPLOVAverage weight of larvae per gram of eggs in each vaccine group.

(71) PPLOCAverage weight of larvae per gram of eggs in the control group.
EF (%)=100[1(CRTCROCRF)]
wherein:

(72) EF (%)Immunogen effectiveness.

(73) CRTReduction in the number of adult females (1DT)

(74) CROReduction in the oviposition capacity (1DO)

(75) CRFReduction in fertility (1DF)

(76) The values obtained for each vaccine group were statistically analyzed by Tukey test.

(77) Humoral Kinetic Studies

(78) The blood collection of animals was done weekly from week 0 to week 14, and the first sample was collected before the first inoculation. The serum obtained from each sample was aliquoted into Eppendorf tubes at 20 C. The kinetics were measured using enzyme immunoassay ELISA.

(79) The Maxisorp plate were coated with a carbonate buffer solution of pH 9.6 (Na.sub.2CO.sub.3 0.159 g; NaHCO.sub.3 0.293 g, H.sub.2O Milli-Q q.s.p. 100 mL), wherein the peptide was diluted in the amount of 2 mg/well, leaving to adsorb at 4 C. overnight. After this period, the plates were washed twice with Wash Buffer solution (NaCl 9.0 g; Tween-20 0.5 mL, H.sub.2O dd q.s.p. 1000 mL) and added to the blocking solutionCasein 2% in PBS pH 7 6 (NaCl 4.25 g; Na.sub.2HPO.sub.4 0.64 g; Na.sub.2HPO.sub.4.H.sub.2O 0.068 g, H.sub.2O Milli-Q q.s.p. 500 mL) for one hour at room temperature. The plates were washed twice and thereafter 100 mL/well of the experimental animals sera was added diluted at 1:100 in Incubation Buffer solution (PBS 87.5 mL pH 7.6, 12.5 mL Casein 2% in PBS pH 7.6; Tween 20 50 mL) and allowed to incubate for two hours at room temperature. The plates were washed six times with wash buffer solution and proceeded with incubation for two hours at room temperature, of the secondary antibodyIgG rabbit anti-IgG bovine conjugated to peroxidase, diluted in incubation buffer solution, the volume of 100 mL/well. The plates were washed six times with wash buffer and added to the developing solution at 100 mL/well of volume comprised of Substrate Buffer 20 mL (Na.sub.2HPO.sub.4 7.19 g, citric acid 5.19 g, and H.sub.2O Milli-Q q.s.p. 1000 mL), O.P.D. 4 mg (q-phenyldiaminebenzene) and H.sub.2O.sub.2 2.5 mL, for a period of 20 minutes in the dark. The reaction was stopped with 30 mL/well of sulfuric acid 1:20. The reading was performed on ELISA reader at 492 nm.

(80) To discriminate the cut point between positive and negative for antibody response measured in ELISA, it was used the addition of two standard deviations from the negative controls.

(81) Statistical Analysis

(82) It was used the analysis of variance (ANOVA) to compare the various tests. For this, it was found that the data met the assumptions of normality and variance of the samples, and thus, the Tukey test was done.

(83) All statistical analysis were performed using the statistical software Sigmastat Version 2006.

(84) Results

(85) The data set for the biological parameters analyzed after counting and weighing teleoginae, weighing eggs and larvae, as well as the reducing parameters of the number and weight of the teleoginae, the egg weight, fertility and efficiency are shown in Table 3. It can be seen that the number of adult ticks (teleoginae) detached from the control group was higher than in the groups immunized with the recombinant peptides, SEQ ID NO: 3 and SEQ ID NO: 4, showing a lower number unfastened form immunized groups, being the reductions statistically significant when compared to the controls, and, also, statistically different reducing of engorged female ticks from animals immunized with the two recombinant peptides. It may also be observed that the detached teleoginae, both from the control group and the immunized with recombinant peptides obtained from the sequences, showed no statistically significant differences between them with respect to the average weight.

(86) By analyzing the average weight of the eggs, it was found that there was no statistically significant difference between the different control groups with each other nor compared these with the results for the group of animals immunized with the recombinant peptide SEQ ID NO: 4; however when comparing the results of the various controls with those obtained in the group of animals immunized with the recombinant peptide SEQ ID NO: 3 they were significantly lower showing statistical difference, there were also statistically significant results among groups of animals immunized being the average weight of the eggs lower in the group immunized with the recombinant peptide SEQ ID NO: 3.

(87) TABLE-US-00003 TABLE 3 Biological parameters of Rhipicephalus (B.) microplus from animals immunized with the recombinant peptides SEQ ID NO: 4 and SEQ ID NO: 3 and control groups of P. pastoris, adjuvant control, Milli-Q water control. The different letters (a, b, c) indicate a statistically significant difference at 0.01% level of significance in Tukey test. BIOLOGICAL PARAMETERS GROUPS Pichia Saponin Milli-Q SEQ ID SEQ ID Control Control Control NO: 4 NO: 3 Number of teleoginae 1049.sup.a 1046.sup.a 1055.sup.a 362.sup.c 522.sup.b detached Average weight of teleoginae 0.2553.sup.a 0.2541.sup.a 0.2558.sup.a 0.2516.sup.a 0.2404.sup.b detached Average weight of oviposition 0.1224.sup.a 0.1380.sup.a 0.1290.sup.a 0.1183.sup.a 0.0901.sup.b Larva weight/gram of eggs 0.0533.sup.a 0.0528.sup.a 0.0557.sup.a 0.0441.sup.b 0.0102.sup.c Weight of eggs reduction 3.35%.sup.a 26.38%.sup.b (OF) teleoginae reduction (DT) 65.49%.sup.a 50.23%.sup.b Fertility reduction (DF) 17.26%.sup.a 80.86%.sup.b Effectiveness (EF) 72.56% 92.99.sup.b

(88) In weighing the ratio larvae/gram eggs, it was observed that there was no statistically significant difference between the different control groups, however when comparing these results with those obtained in groups of animals immunized with the recombinant peptides SEQ ID NO: 4, SEQ ID NO: 3 there was a decrease in weight ratio, with a statistically significant difference; between the groups of animals immunized the ratio was lower in the animals immunized with the recombinant peptide SEQ ID NO: 3 showing statistically significant difference between the groups immunized. When comparing the percentage factors of decreased egg weight, the amount of teleoginae, and the reduced fertility, one concludes that recombinant peptides obtained from the sequences described achieved a significant level of reduction and efficiency. The kinetics of recombinant anti-peptides antibody (IgG) is presented as a typical IgG immune response produced by integrating a protein used as antigen and these results are shown in FIGS. 1 and 2.

(89) The recombinant peptides SEQ ID NO: 3 and SEQ ID NO: 4, when inoculated on bovines, do not cause any discomfort or adverse reaction in the inoculated animals.

CONCLUSION

(90) A vaccine for Rhipicephalus (B.) microplus tick control based on recombinant peptides obtained from the sequences described has advantages because the developed vaccine is a flock vaccine in which the vaccination of the herd for three annual cycles decreases the tick population, which leads to minimization of losses already mentioned, and avoid the use of 19 or 20 baths of acaricide as it is currently being done in many farms of the country.

(91) This invention has high social and environmental impact because currently there is the need to meet consumer demands for food free of chemicals, protection of the environment, and consequently the wild animals. Thus, in a market where the products to combat ectoparasites are mainly chemicals, it is necessary to invest in research and manufacture of alternative products for the control of these agents.

(92) The vaccines are safe, have a good interface with the environment, and are more readily accepted by consumers, perhaps by the familiarity they have with the vaccine used in human medicine. With its use, there is a greater increase in animal production and productivity than with the use of other medications.

(93) Unlike vaccines, the chemicals used today for combating ticks are highly toxic. If the cattle is treated with acaricide and the grace period is not respected, meat and milk should not be intended for human consumption because they are subject to the risk of poisoning, which, for prolonged periods, can lead to harmful effects on human being.

(94) The production method of recombinant peptides used as vaccine is easier to industrial level, allows complete reproducibility on a large scale, and is more economical for low-cost production at the industrial level.